COVID-19 (Coronavirus) Update: Testing and Information | Vaccine Updates | Visitor Guidelines

Testing the Addition of Radiation Therapy to the Usual Immune Therapy Treatment (Atezolizumab) for Extensive Stage Small Cell Lung Cancer, The RAPTOR Trial

Protocol No
NRG-LU007
Principal Investigator
Jonathan Thompson
Phase
II/III
Summary
This study is being done to answer the following question: Can we extend the time without your extensive small cell lung cancer growing or spreading by adding radiation therapy to the usual treatment for this type of cancer (an immunotherapy drug called atezolizumab)? We are doing this study because we want to find out if this approach is better or worse than the usual approach for your type of cancer. The usual approach is defined as care most people get for extensive stage small cell lung cancer.
Description
Testing the addition of radiation therapy to the usual immune therapy treatment (atezolizumab) for patients with extensive stage small cell lung cancer
Participating Institutions
Froedtert West Bend Hospital
Froedtert Menomonee Falls Hospital
Froedtert Hospital
Status
OPEN TO ACCRUAL
Sub Category